Chamindie Punyadeera
Overview
Explore the profile of Chamindie Punyadeera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
2917
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perera G, Huang X, Bagherjeri F, Joglekar C, Leo P, Duijf P, et al.
Biosens Bioelectron
. 2025 Feb;
276:117252.
PMID: 39978233
Tumour protein p53 (TP53) is a tumour suppressor gene that is frequently mutated in cancers. Traditional TP53 detection methods, such as polymerase chain reactions, are time-consuming and demand skilled laboratory...
2.
Flintoff J, Pattinson C, Ahamed S, Ali S, Bagley A, Broszczak D, et al.
BMJ Open Sport Exerc Med
. 2025 Feb;
11(1):e002410.
PMID: 39897983
Understanding and predicting individual responses to common stressors is essential for optimising performance in high-stress environments. This article outlines a protocol for a study to identify biomarkers that predict performance...
3.
Carlton M, Zang T, Parker T, Punyadeera C, Voisey J, Cuttle L
Proteomics Clin Appl
. 2025 Feb;
19(2):e202300107.
PMID: 39895030
Saliva is a child appropriate biofluid, but it has not previously been used to evaluate the systemic response to burn injury in children. The aim of this study was to...
4.
Afridi W, Picos S, Bark J, Stamoudis D, Vasani S, Irwin D, et al.
Cancer Metastasis Rev
. 2025 Jan;
44(1):29.
PMID: 39888565
CT chest scans are commonly performed worldwide, either in routine clinical practice for a wide range of indications or as part of lung cancer screening programs. Many of these scans...
5.
Wong M, Vasani S, Breik O, Zhang X, Kenny L, Punyadeera C
Cancer Med
. 2024 Aug;
13(16):e70129.
PMID: 39169896
Background: Head and neck malignancy, and in particular squamous cell carcinoma (SCC), is responsible for a significant disease burden globally. The lack of an optimal in vitro model system to...
6.
Zhang X, Weeramange C, Hughes B, Vasani S, Liu Z, Warkiani M, et al.
Cell Mol Life Sci
. 2024 May;
81(1):233.
PMID: 38780775
Patients with head and neck squamous cell carcinoma (HNSCC) are at a high risk of developing recurrence and secondary cancers. This study evaluates the prognostic and surveillance utilities of circulating...
7.
Paper electrochemical immunosensor for the rapid screening of Galectin-3 patients with heart failure
Nihal S, Sarfo D, Zhang X, Tesfamichael T, Karunathilaka N, Punyadeera C, et al.
Talanta
. 2024 Mar;
274:126012.
PMID: 38554482
A paper electrochemical immunosensor for the combined binding and quantification of the heart failure (HF) biomarker Galectin-3 has been developed. The simple design of the new sensor is comprised of...
8.
Wijesekera A, Weeramange C, Vasani S, Kenny L, Knowland E, Seneviratne J, et al.
Tumour Virus Res
. 2024 Mar;
17:200278.
PMID: 38442788
Human papillomavirus (HPV) is the most common sexually transmitted disease. Certain strains have the potential to cause malignancy in multiple anatomical sites if not cleared by the immune system. In...
9.
Balakittnen J, Weeramange C, Wallace D, Duijf P, Cristino A, Hartel G, et al.
Int J Oral Sci
. 2024 Feb;
16(1):14.
PMID: 38368395
Oral cancer (OC) is the most common form of head and neck cancer. Despite the high incidence and unfavourable patient outcomes, currently, there are no biomarkers for the early detection...
10.
Weeramange C, Tang K, Irwin D, Hartel G, Langton-Lockton J, Ladwa R, et al.
Carcinogenesis
. 2024 Jan;
45(3):140-148.
PMID: 38270218
Despite the rising incidence, currently, there are no early detection methods for HPV-driven HNC (HPV-HNC). Cervical cancer studies suggest that HPV DNA methylation changes can be used as a biomarker...